Clinical Trial

Liberty Analyzer WBC System: Reference Interval Study

Study acronym: REFINE
Suspended
View on ClinicalTrials.gov →
Why the trial stopped
For interim analysis.
Summary
The purpose of this study is to establish the reference intervals for WBC and granulocytes for the Liberty Analyzer WBC System.
Protocol Amendment History 2 changes
critical Trial status changed: Enrolling by Invitation → Suspended 2026-08-08
critical Recruitment suspended: For interim analysis. 2026-08-08
Trial Details
NCT Number NCT07031882
Lead Sponsor Entia Ltd
Conditions Healthy Volunteers
Enrollment 300 participants
Start Date 2026-03-19
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07